A single dose of the Jynneos mpox vaccine reduces hospitalization risk and disease severity, a study found, although researchers emphasized that people at risk for the disease should complete the two-dose vaccine series.
According to the study of roughly 6,000 people diagnosed with mpox in the United States, researchers found that 2.1% of vaccinated people and 7.5% of unvaccinated people were hospitalized. The risk for symptoms among vaccinated people before illness onset was also “significantly lower” than those who were not vaccinated.
“One dose of Jynneos vaccine might